Global Injectable Drug Delivery Devices Pipeline Assessment Report 2020 – ResearchAndMarkets.com

Global Injectable Drug Delivery Devices Pipeline Assessment Report 2020 – ResearchAndMarkets.com




Global Injectable Drug Delivery Devices Pipeline Assessment Report 2020 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Injectable Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.

“Injectable Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020”. Injectable Drug Delivery Devices are defined as administration of a drug into patient’s blood through a delivery device.

Scope

  • Extensive coverage of the Injectable Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Injectable Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Injectable Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Injectable Drug Delivery Overview

3 Products under Development

3.1 Injectable Drug Delivery – Pipeline Products by Stage of Development

3.2 Injectable Drug Delivery – Pipeline Products by Segment

3.3 Injectable Drug Delivery – Pipeline Products by Territory

3.4 Injectable Drug Delivery – Pipeline Products by Regulatory Path

3.5 Injectable Drug Delivery – Pipeline Products by Estimated Approval Date

3.6 Injectable Drug Delivery – Ongoing Clinical Trials

4 Injectable Drug Delivery – Pipeline Products under Development by Companies

4.1 Injectable Drug Delivery Companies – Pipeline Products by Stage of Development

4.2 Injectable Drug Delivery – Pipeline Products by Stage of Development

5 Injectable Drug Delivery Companies and Product Overview

6 Injectable Drug Delivery- Recent Developments 2137 Appendix

7 Appendix

Companies Mentioned

  • Adalvo
  • Adamis Pharmaceuticals Corp
  • AdrenaCard, Inc.
  • AktiVax Inc.
  • Allergan Ltd
  • Alsensa ApS
  • Antares Pharma Inc
  • Aquavit Pharmaceuticals Inc
  • Artemes Technologies, Inc.
  • Ascendis Pharma A/S
  • ASCIL Biopharm
  • ASIS Corp
  • AzureBio SL
  • Bespak Europe Ltd
  • Biocorp Production SA
  • 1BioCorRx Inc
  • BioRestorative Therapies Inc
  • Bioxis Pharmaceuticals
  • Brigham and Women’s Hospital
  • Burke Pharmaceuticals LLC
  • Calla Health Foundation
  • Callisyn Biomedical Inc
  • Cambridge Consultants Ltd
  • Camurus AB
  • Case Western Reserve University
  • Cincinnati Children’s Hospital Medical Center
  • Clearside BioMedical Inc
  • DALI Medical Devices Ltd.
  • DelSite, Inc. (Inactive)
  • Drexel University
  • Duoject Medical Systems Inc
  • Ecole Polytechnique Federale de Lausanne
  • Elcam Medical
  • EmboMedics Inc
  • Embryyo Technologies Pvt Ltd
  • Emergent BioSolutions Inc
  • EP Global Communications Inc (Inactive)
  • Eveon SAS
  • EyePoint Pharmaceuticals Inc
  • FHC Inc
  • GeneSYS-ID Inc
  • Georgia Institute of Technology
  • Ghent University
  • Globe Medical Tech Inc (Inactive)
  • Hoffmann-La Roche Inc
  • Inovio Pharmaceuticals Inc
  • InVivo Therapeutics Corp
  • Ionic Pharmaceuticals LLC
  • JCR Pharmaceuticals Co Ltd
  • komarik
  • Kyowa Kirin Ltd
  • Lohmann Therapie-Systeme AG
  • 5LyoGo
  • Mallinckrodt Plc
  • Mercator MedSystems Inc
  • Mertiva AB
  • Midas Pharma GmbH
  • Milestone Scientific Inc
  • 5Millendo Therapeutics Inc
  • Morimoto Pharma Co Ltd
  • NanoPass Technologies Ltd
  • Novo Nordisk AS
  • Novosanis NV
  • Osteo Pharma BV
  • Oval Medical Technologies Ltd
  • Owen Mumford Ltd
  • Palatin Technologies Inc
  • Particle Therapeutics Ltd
  • Portal Instruments Inc
  • Prohibix LLC
  • QuiO Technologies LLC
  • Regeneron Pharmaceuticals Inc
  • RepliCel Life Sciences Inc
  • Rescitech Vision Pvt Ltd
  • RetinaPharma Technologies Inc
  • Sapporo Medical University School of Medicine
  • Schott AG
  • Subcuject ApS
  • Sunshine Guojian Pharmaceutical Shanghai Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • TCB medical devices
  • Terumo Corp
  • Teva Pharmaceutical Industries Ltd
  • TheraKine Inc (Inactive)
  • Twin Star Medical Inc
  • Unilife Corporation
  • University of Calgary
  • University of California San Diego
  • University of California San Francisco
  • University of Delaware
  • University of Dundee
  • University of Florida
  • University of New Mexico
  • University of Saskatchewan
  • University of Texas at Austin
  • Vanderbilt University
  • West Pharmaceutical Services Inc
  • Windgap Medical Inc
  • XERIS Pharmaceuticals Inc
  • Ypsomed Holding AG
  • Zosano Pharma Corp

For more information about this report visit https://www.researchandmarkets.com/r/pdw4og

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900